Clinical trials: Pharmacist
Diabetes Mellitus
Transforming Diabetes Care: Pharmacist-Led Education and Its Impact on Patient Knowledge, Self-Management, and Health Outcomes
This interventional study is to evaluate the impact of pharmacist-led education on diabetic patients' knowledge, self-management, and overall health outcomes.
- Trial name
- TRIPLE-CARE (NCT06807333)
- Testing
- Pharmacist led Education
- Where
- Pakistan
- Volunteers
- 385 people
- Sponsor
- Shifa International Hospital
Smoking Cessation, Smoking, Tobacco
Evaluation of an Intensive Individualized Smoking Cessation Program Delivered by Pharmacists
This study aims to look at the efficacy and impact of a pharmacist-led smoking cessation program. It will assess an intensive program and an abbreviated program, with the latter being evaluated for feasibility in community…
- Conditions
- Smoking Cessation, Smoking, Tobacco, Quality of Life
- Trial name
- NCT03597607
- Testing
- Intensive Smoking Cessation Group, Abbreviated Smoking Cessation Group
- Where
- Canada
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- Memorial University of Newfoundland
Hypertension, Primary Hypertension
Effectiveness of SMS Reminders of Blood Pressure-lowering Drugs Intake
By conducting the SPPA trial we try to find out, whether personalized Short Message Service (SMS) reminders of blood pressure-lowering medication can effectively increase patients' adherence to blood pressure-lowering medication.
- Conditions
- Hypertension, Primary Hypertension, Non-Adherence, Medication, Non-Adherence, Patient
- Trial name
- SPPA (NCT03105687)
- Testing
- SMS reminders of medicines intake
- Where
- 24 sites in Slovakia
- Volunteers
- 300 people
- Sponsor
- Comenius University
Transitional Care Coordination, Home Visits
Collaborative Home Visits to Reduce Hospital Readmissions and Improve Medication Use During Transitions of Care
The primary objective is to develop a sustainable practice model emphasizing home visits by a collaborative physician and pharmacist team to decrease unplanned emergency department visits and hospital readmissions at 30 and 90…
- Trial name
- NCT02087072
- Testing
- Collaborative visit with provider and pharmacist
- Where
- United States
- Sponsor
- Ohio State University
Type 2 Diabetes Mellitus
Pharmacist Counseling on the Health-related Quality of Life of Patients With Type 2 Diabetes Mellitus
The quality of life (QoL) of patients with type 2 diabetes mellitus (T2DM) is a measure of the successful outcomes of therapy. The program of management of chronic diseases "Program Pengelolaan Penyakit Kronis" (Prolanis) among…
- Trial name
- NCT04313829
- Testing
- Pharmacist Counseling Intervention
- Where
- 4 sites in Indonesia
- Volunteers
- 220 people
- Sponsor
- Universitas Padjadjaran
Alcohol Use Disorder (AUD), Pharmacist-Patient Relations
Alcohol Telemedicine Consultation in Primary Care (ATC)
This pragmatic, cluster-randomized trial in adult primary care clinics in a healthcare system with a diverse membership will examine the effectiveness of an innovative, multi-faceted intervention, the Addiction Telemedicine…
- Conditions
- Alcohol Use Disorder (AUD), Pharmacist-Patient Relations, Alcohol Problem
- Trial name
- ATC (NCT05252221)
- Testing
- ATC Intervention
- Where
- 2 sites in United States
- Volunteers
- 41,843 people
- Sponsor
- Kaiser Permanente
Chronic Kidney Disease
Impact of CAMP in an Ambulatory Renal Clinic
The purpose of this study is to see if a pharmacist can help patients understand how he/she should be taking their medications. The study is also being done to see if meeting with the pharmacist can help patients better control…
- Trial name
- CAMP (NCT00599365)
- Testing
- Pharmacy care arm
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- San Francisco Veterans Affairs Medical Center
Tobacco Cessation, Health Warning Label
Health Warnings and Counseling for Smoking Cessation
Tobacco use remains persistently high across South Asia, despite numerous public health efforts, and continues to significantly contribute to the burden of non-communicable diseases (NCDs) such as cardiovascular disease…
- Conditions
- Tobacco Cessation, Health Warning Label, Hypertension, Non Communicable Chronic Diseases
- Trial name
- NCT07098065
- Testing
- Graphical health warnings, Graphical health warnings plus pharmacist-led counselling, Routine pharmacy services (no intervention)
- Where
- Bangladesh
- Volunteers
- 3,400 people
- Sponsor
- Hitotsubashi University
Hypercholesterolemia
A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering Treatment
The objective of the study is to test the effectiveness of a community pharmacist-led intervention to increase adherence to lipid lowering treatment.
- Trial name
- NCT00493337
- Testing
- advanced adherence counseling+reminder, Compliance Card
- Where
- Netherlands
- Volunteers
- 373 people
- Sponsor
- Utrecht Institute for Pharmaceutical Sciences
Neoplasm
Evaluation of the Impact of the Clinical Pharmacist in Oral Therapies in Oncology.
The hospital pharmacist plays a vital role at the time of the patient's first prescription in a healthcare facility, to inform the patient about his or her new therapy and create a link between the hospital and the patient's home…
- Trial name
- PHARMAIMPACT2 (NCT06980012)
- Testing
- Pharmaceutical consultation, Pharmaceutical consultation and follow-up
- Where
- France
- Volunteers
- 90 people
- Sponsor
- Polyclinique Lyon Nord
Pharmaceutical Preparations, Accidental Fall
The Patient Experience of a Paramedic-Pharmacist Referral Pathway for Clinical Medication Reviews
This study seeks to understand how patients feel about their medicines before and after receiving a clinical medication review.
- Conditions
- Pharmaceutical Preparations, Accidental Fall, Allied Health Personnel
- Trial name
- PEPPR (NCT03938428)
- Testing
- Survey
- Where
- United Kingdom
- Volunteers
- 132 people
- Sponsor
- Yorkshire Ambulance Service NHS Trust
Respiratory Disease, Cardiovascular Diseases
Hospice Quality Score Assessment Post Pharmacist Intervention
The study aims to investigate the impact of pharmacist delivered interventions on hospice patients quality metric scores.
- Conditions
- Respiratory Disease, Cardiovascular Diseases, Neurologic Disorder, Dementia
- Trial name
- NCT04361669
- Testing
- Medication safety review
- Where
- United States
- Sponsor
- Tabula Rasa HealthCare
Contraception, Pharmaceutical Services
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
The goal of this clinical trial is to learn if use of the HAPPI software can improve pharmacist-provided birth control services. The main questions it aims to answer are: 1.
- Conditions
- Contraception, Pharmaceutical Services, Access and Linkage to Healthcare, Technology Use
- Trial name
- HAPPI (NCT06823037)
- Testing
- HAPPI software
- Where
- United States
- Volunteers
- 150 people
- Sponsor
- EMPOWERX INC
TB - Tuberculosis, Patient Satisfaction
To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic
The COVID-19 pandemic might be an opportunity to review and refine our practices in anti TB treatment. For the follow-up of selected patients, telephone consultations may be efficient and cost-effective.
- Trial name
- Coronavirus19 (NCT04412239)
- Testing
- Patient-centred advice on Telephone Consultation in TB Patients:
- Where
- 2 sites in Pakistan
- Volunteers
- 200 people
- Sponsor
- Xi'an Jiaotong University
Rationalization
The Economic Impact of Clinical Pharmacist Involvement in the Public Procurement for Medicines and in the Drug and Therapeutics Committee
The investigators have performed cost-minimisation analysis and compared the expenses based on the plan for public procurement (without clinical pharmacist involvement) for drugs with the results of public procurement based on…
- Trial name
- NCT04314336
- Testing
- Public procurement, Drug and Therapeutics Committee
- Where
- Croatia
- Volunteers
- 10,000 people
- Sponsor
- Bjelovar General Hospital
Epilepsy
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
The purpose of this interventional study is to assess the impact of pharmacist-led cognitive behavioral intervention in epileptic patients. The main questions are: 1.
- Trial name
- COGNIPHARM-I (NCT06034353)
- Testing
- Pharmacist-led Cognitive Behavioral therapy
- Where
- Pakistan
- Volunteers
- 385 people
- Sponsor
- Hamdard University
Opioid Dependence
DE-eSCALation of Opioids Post-surgical dischargE
The Descale Study aims to: 1. Look at the prescribing trends of opioids and the scale of long-term use following surgery within East Kent (United Kingdom) 2.
- Trial name
- DESCALE (NCT06396663)
- Testing
- Rapid Opioid de-escalation, Gradual Opioid de-escalation, Continuation of opioids
- Where
- United Kingdom
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- University of Kent
Hypertension
The Effectiveness of the Android Application as a Pharmaceutical Education Tool in Hypertensive Patients
Hypertension is a worldwide public health challenge due to its high prevalence and along with increased risk of complications of other diseases that are more dangerous if not managed properly.
- Trial name
- NCT05728723
- Testing
- Android Application, Pharmacy education
- Where
- Indonesia
- Volunteers
- 100 people
- Sponsor
- Universitas Padjadjaran
Medication Safety
Pharmacist and Data Driven Quality Improvement in Primary Care
P-DQIP is an intervention to improve prescribing safety in primary care. The 'intervention' is a health board quality improvement programme that will be implemented across all practices in one National Health Service (NHS) board…
- Trial name
- P-DQIP (NCT03747107)
- Testing
- P-DQIP
- Where
- United Kingdom
- Volunteers
- 19 people
- Sponsor
- University of Dundee
Breast Cancer Early Stage Breast Cancer (Stage 1-3), Endocrine Therapy
Symptom Monitoring Using Patient-Report to Improve Medication Use
This is an intervention targeting patients at risk for non-adherence to endocrine therapy after primary treatments for hormone-positive breast cancer.
- Trial name
- SyMPTOM (NCT06765707)
- Testing
- Pharmacist delivered symptom monitoring and management
- Where
- 4 sites in United States
- Volunteers
- 225 people
- Sponsor
- Medical College of Wisconsin